Nonprofit · EIN 52-1800187
PLASMA PROTEIN THERAPEUTICS ASSOCIATION
Tax-exempt · ANNAPOLIS, MD 21401
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2025 | 990 | $14,575,171 | $15,873,570 | -$1,298,399 | $11,603,413 | $4,660,962 | $6,942,451 |
| December 31, 2024 | 990 | $14,975,704 | $16,177,207 | -$1,201,503 | $12,791,836 | $4,737,253 | $8,054,583 |
| December 31, 2023 | 990 | $15,001,344 | $14,444,061 | $557,283 | $12,157,727 | $3,203,661 | $8,954,066 |
Financial details: 990 for the year ended December 31, 2025
Revenue
- Contributions, gifts and grants
- $0
- Program service revenue
- $14,389,172
- Investment income
- $94,669
- Other revenue
- $91,330
Expenses
- Grants and similar amounts paid
- $0
- Compensation of officers, directors and key employees
- $2,364,976
- Other salaries and wages
- $2,450,604
- Salaries, compensation and benefits (total)
- $5,121,672
- Professional fundraising fees
- $0
- Occupancy
- $468,990
- Travel
- $289,237
- Depreciation
- $3,170
Balance sheet and other
- Total assets, start of year
- $12,791,836
- Total assets, end of year
- $11,603,413
- Total liabilities, end of year
- $4,660,962
- Net assets, end of year
- $6,942,451
- Land, buildings and equipment
- $694
- Publicly traded securities
- $4,386,794
- Net assets without donor restrictions
- $6,942,451
- Gross unrelated business income
- $69,575
- Gross receipts
- $14,575,171
- Employees
- 25
- Volunteers
- 3
- Year formed
- 1992
- State of legal domicile
- MD
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| ANITA SPEAR | PRESIDENT & Officer | 40 | $747,615 | $41,739 |
| JOSHUA PENROD | SR VP GLOBAL Key employee | 40 | $523,225 | $54,279 |
| JAMES KNOWLES | SR DIR GLOB. Key employee | 40 | $306,450 | $43,805 |
| EUGENE STROSHANE | VP FINANCE & Officer | 40 | $287,092 | $59,886 |
| JULIE BIRKOFER | SR VP N. AME Highest-paid employee | 40 | $284,280 | $26,070 |
| SHARON PEARCE | VP GOV. AFFA Key employee | 40 | $266,890 | $33,994 |
| ILANA OSTRIN | SR DIR. GLOB Highest-paid employee | 40 | $238,270 | $24,784 |
| JULIA FABENS | SR DR, GLOBA Highest-paid employee | 40 | $221,670 | $39,660 |
| MICHAEL MCCORMICK | DIR IT & FAC Highest-paid employee | 40 | $197,290 | $50,603 |
| CATHERINE IZZI | SR. DIR, HR Highest-paid employee | 40 | $180,884 | $52,463 |
| DAVID BELL | GLOBAL BOARD Trustee or director | 1 | $0 | $0 |
| PAOLO MARCUCCI | GLOBAL TREAS Trustee or director | 1 | $0 | $0 |
| GILES PLATFORD | GLOBAL EXEC. Trustee or director | 1 | $0 | $0 |
990 for the year ended December 31, 2024: 13 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| ANITA BRIKMAN | PRESIDENT & Officer | 40 | $701,055 | $63,685 |
| JOSHUA PENROD | SR VP GLOBAL Key employee | 40 | $508,697 | $42,721 |
| JULIE BIRKOFER | SR VP N. AME Former | 40 | $499,302 | $38,682 |
| WILLIAM SPEIR | SR DIR STATE Highest-paid employee | 40 | $294,322 | $55,430 |
| EUGENE STROSHANE | VP FINANCE Officer | 40 | $276,206 | $58,867 |
| JAMES KNOWLES | SR DIR GLOB. Key employee | 40 | $216,308 | $31,583 |
| MICHAEL MCCORMICK | DIR IT & FAC Highest-paid employee | 40 | $199,353 | $47,196 |
| THOMAS LILBURN | SR. DIR GOVT Highest-paid employee | 40 | $187,574 | $34,835 |
| DANIEL SEATON | DIR PUBLIC A Highest-paid employee | 40 | $187,719 | $21,705 |
| ILANA OSTRIN | SR DIR. GLOB Highest-paid employee | 40 | $174,536 | $14,383 |
| DAVID BELL | GLOBAL BOARD Trustee or director | 1 | $0 | $0 |
| PAOLO MARCUCCI | GLOBAL TREAS Trustee or director | 1 | $0 | $0 |
| GILES PLATFORD | GLOBAL CHAIR Trustee or director | 1 | $0 | $0 |
990 for the year ended December 31, 2023: 12 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| JULIE BIRKOFER | SR VP PUBLIC Key employee | 40 | $456,280 | $36,452 |
| JOSHUA PENROD | SR VP GLOBAL Key employee | 40 | $437,614 | $40,315 |
| ANITA BRIKMAN | PRESIDENT & Officer | 40 | $311,819 | $10,626 |
| WILLIAM SPEIR | SR DIR STATE Highest-paid employee | 40 | $258,495 | $54,223 |
| THOMAS LILBURN | SR DIR GOV R Highest-paid employee | 40 | $260,755 | $49,735 |
| EUGENE STROSHANE | VP FINANCE Officer | 40 | $252,957 | $52,445 |
| MICHAEL MCCORMICK | DIR IT & FAC Highest-paid employee | 40 | $176,828 | $46,223 |
| CATHERINE IZZI | SR DIR HUMAN Highest-paid employee | 40 | $146,441 | $44,491 |
| DANIEL SEATON | DIR PUBLIC A Highest-paid employee | 40 | $150,179 | $18,784 |
| DAVID BELL | GLOBAL BOARD Trustee or director | 1 | $0 | $0 |
| PAOLO MARCUCCI | GLOBAL TREAS Trustee or director | 1 | $0 | $0 |
| GILES PLATFORD | GLOBAL CHAIR Trustee or director | 1 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 147 OLD SOLOMONS ISLAND RD STE 100, ANNAPOLIS, MD 21401-3822
- Principal officer (990 for 2025)
- EUGENE STROSHANE
- Signed the 990
- EUGENE STROSHANE, VP FINANCE & OPS
- Phone
- (443) 458-4676
- Website
- WWW.PPTAGLOBAL.ORG
- Return prepared by
- COMPASS US ACCOUNTANTS & ADVISORS
Mission
PPTA DRIVES BROAD AND RELIABLE ACCESS TO HIGH-QUALITY PLASMA PROTEIN THERAPIES, WITH A FOCUS ON THE WELL-BEING OF PATIENTS AND PLASMA DONORS.
Program accomplishments
- AS A TRUSTED PARTNER TO HEALTH SYSTEMS, PPTA DRIVES BROAD AND RELIABLE ACCESS TO HIGH-QUALITY PLASMA PROTEIN THERAPIES, WITH A FOCUS ON THE WELL- BEING OF PATIENTS AND PLASMA DONORS. THE PLASMA PROTEIN THERAPEUTICS ASSOCIATION (PPTA) REPRESENTS A UNIQUE SECTOR OF THE BIOLOGICS AND BIOTECHNOLOGY INDUSTRY. PPTA REPRESENTS MORE THAN 1,000 HUMAN PLASMA COLLECTION CENTERS IN NORTH AMERICA AND EUROPE, AS WELL AS THE MANUFACTURERS OF LIFESAVING PLASMA PROTEIN THERAPIES. OUR MEMBERS PRODUCE APPROXIMATELY 80% OF THE PLASMA PROTEIN THERAPIES IN THE U.S. AND 60% OF THOSE MANUFACTURED IN EUROPE. PPTA WORKS GLOBALLY TO ADVOCATE FOR PATIENT ACCESS TO PLASMA-DERIVED MEDICINES, RESPONSIBLY IMPROVE THE AVAILABILITY OF PLASMA, AND ADVANCE THE UNDERSTANDING OF THE PLASMA ECOSYSTEM: -PROMOTE CLINICIAN AUTHORITY AND PATIENT PARTICIPATION IN TREATMENT DECISIONS -PURSUE REIMBURSEMENT MODELS RECOGNIZING THE UNIQUE NATURE OF PLASMA PROTEIN THERAPIES -SHAPE DECISIONS OF AUTHORITIES TO IMPROVE PLASMA PROTEIN THERAPY AVAILABILITY -FORAGE PARTNERSHIPS THAT SUPPORT PATIENT-FOCUSED INITIATIVES -ADVOCATE FOR GLOBAL SUFFICIENCY OF PLASMA -PIONEER PLASMA SAFETY AND MANUFACTURING QUALITY AND SUPPORT DONOR WELL- BEING -DRIVE PROGRESSIVE POLICIES FOR PLASMA COLLECTIONS -ENCOURAGE PLASMA DONATION, GLOBALLY -GENERATE AND PROMOTE EVIDENCE-BASED INFORMATION ABOUT PLASMA -EXPLAIN THE IMPORTANCE, UNIQUE NATURE, AND VALUE OF PLASMA PROTEIN THERAPIES PLASMA AND PLASMA COLLECTION: PLASMA IS THE CLEAR, STRAW-COLORED LIQUID PORTION OF BLOOD THAT REMAINS AFTER RED BLOOD CELLS, WHITE BLOOD CELLS, PLATELETS AND OTHER CELLULAR COMPONENTS ARE REMOVED. IT IS THE SINGLE LARGEST COMPONENT OF HUMAN BLOOD, COMPRISING ABOUT 55 PERCENT, AND CONTAINS WATER, SALTS, ENZYMES, ANTIBODIES AND OTHER PROTEINS. -COMPOSED OF 90% WATER, PLASMA IS A TRANSPORTING MEDIUM FOR CELLS AND A VARIETY OF SUBSTANCES VITAL TO THE HUMAN BODY. -PLASMA CARRIES OUT A VARIETY OF FUNCTIONS IN THE BODY, INCLUDING CLOTTING BLOOD, FIGHTING DISEASES AND OTHER CRITICAL FUNCTIONS. -SOURCE PLASMA IS PLASMA THAT IS COLLECTED FROM HEALTHY, VOLUNTARY DONORS THROUGH A PROCESS CALLED PLASMAPHERESIS AND IS USED EXCLUSIVELY FOR FURTHER MANUFACTURING INTO FINAL THERAPIES (FRACTIONATION). SOURCE PLASMA DONORS MAY BE COMPENSATED FOR THEIR TIME AND EFFORT. -RECOVERED PLASMA IS COLLECTED THROUGH WHOLE BLOOD DONATION IN WHICH PLASMA IS SEPARATED FROM ITS CELLULAR COMPONENTS. RECOVERED PLASMA MAY BE USED FOR FRACTIONATION. SOURCE PLASMA IS COLLECTED THROUGH A PROCESS CALLED PLASMAPHERESIS. IN MORE THAN 1,000 SPECIALIZED DONATION CENTERS LOCATED IN THE U.S. AND EUROPE, INDIVIDUALS MAY DONATE PLASMA. PLASMAPHERESIS IS A STERILE, SELF-CONTAINED, AUTOMATED PROCESS THAT SEPARATES PLASMA FROM RED BLOOD CELLS AND OTHER CELLULAR COMPONENTS WHICH ARE THEN RETURNED TO THE DONOR. SOURCE PLASMA COLLECTION IN THE U.S. IS REGULATED BY THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) AND, IN EUROPE, BY THE EUROPEAN MEDICINES AGENCY (EMA) AND NATIONAL REGULATORY AUTHORITIES. PLASMA MANUFACTURING: SOURCE AND RECOVERED PLASMA IS THE STARTING MATERIAL USED TO MANUFACTURE LIFESAVING THERAPIES. THE MANUFACTURING PROCESS IS KNOWN AS FRACTIONATION. PROTEINS ARE SEPARATED THROUGH THIS PROCESS TO CREATE NUMEROUS PLASMA PROTEIN THERAPIES. THIS PROCESS IS CARRIED OUT USING WELL-ESTABLISHED PURIFICATION METHODS SUCH AS PRECIPITATION, CENTRIFUGATION, SEPARATION, AND FILTRATION. PLASMA IS POOLED AND PROCESSED THROUGH A PROCESS CALLED "FRACTIONATION" THAT EMPLOYS TIME, TEMPERATURE, PH, AND ALCOHOL CONCENTRATIONS TO EXTRACT SPECIFIC THERAPEUTIC PROTEINS. THESE ARE THEN SUBJECTED TO VARIOUS PURIFICATION METHODS AND VIRAL INACTIVATION AND REMOVAL PROCESSES TO FURTHER ENSURE THEIR SAFETY AND EFFICACY. PREPARING A THERAPY OFTEN TAKES FROM 7-12 MONTHS BETWEEN DONATION AND FINAL PRODUCT RELEASE. THIS SETS THE PRODUCTION OF PLASMA PROTEIN THERAPIES APART FROM CHEMICAL PHARMACEUTICALS AND OTHER BIOLOGICS WHOSE MANUFACTURING PROCESSES ARE MUCH MORE CONDENSED AND WHOSE DIRECT MANUFACTURING COSTS ARE A SIGNIFICANTLY SMALLER PORTION OF THE OVERALL COST. VOLUNTARY STANDARDS: IN ADDITION TO MEETING REGULATORY REQUIREMENTS, PPTA MEMBER SOURCE PLASMA COLLECTION CENTERS ARE ALSO CERTIFIED BY THE INTERNATIONAL QUALITY PLASMA PROGRAM (IQPP); A RIGOROUS, VOLUNTARY PROGRAM THAT GOES BEYOND REGULATORY REQUIREMENTS TO HELP ENSURE DONOR SAFETY AND FURTHER IMPROVE THE QUALITY OF SOURCE PLASMA USED FOR FRACTIONATION. THESE STANDARDS FOCUS ON DONOR MANAGEMENT, DONOR HEALTH AND CENTER MANAGEMENT: -COMMUNITY-BASED DONORS -DONOR ADVERSE EVENTS REPORTING -DONOR EDUCATION -DONOR FLUID ADMINISTRATION -DONOR DEFERRAL REGISTRY -QUALIFIED DONOR -VIRAL MARKER -CENTER PERSONNEL EDUCATION AND TRAINING -PROFESSIONAL FACILITY -QUALITY ASSURANCE PPTA HAS ALSO ESTABLISHED THE QUALITY STANDARDS OF EXCELLENCE AND LEADERSHIP (QSEAL) PROGRAM TO PROVIDE INDEPENDENT CERTIFICATION OF ADHERENCE BY FRACTIONATORS TO THE VOLUNTARY STANDARDS. THESE VOLUNTARY STANDARDS COVER: -CONTROLS ON INCOMING PLASMA -INVENTORY HOLD -TESTING FOR HIV, HBV, HCV, HAV AND PARVOVIRUS B19 -INTERMEDIATES PURCHASED FROM AN EXTERNAL SUPPLIER -RECOVERED PLASMA -QUALIFIED DONOR -VIRAL MARKER NATIONAL DONOR DEFERRAL REGISTRY: THE NATIONAL DONOR DEFERRAL REGISTRY (NDDR) HELPS ENSURE THAT DEFERRED DONORS CANNOT DONATE THEIR PLASMA AGAIN. THE NDDR IS A DATABASE OF PERMANENTLY DEFERRED PLASMA DONORS IN NORTH AMERICA. IT IS ONE OF MANY VOLUNTARY, SELF-REGULATING INITIATIVES TAKEN BY THE SOURCE PLASMA COLLECTION INDUSTRY AND IS AN IMPORTANT COMPONENT OF THE INDUSTRY-DRIVEN SAFETY MEASURES THAT HELP ENSURE THE SAFETY OF THE FINAL THERAPIES. PATIENT NOTIFICATION SYSTEM: IN 1998, THE PLASMA PROTEIN THERAPEUTICS ASSOCIATION (PPTA) AND ITS MEMBERS COLLABORATED WITH PATIENT ORGANIZATIONS TO DEVELOP THE PATIENT NOTIFICATION SYSTEM (PNS). THIS SYSTEM PROVIDES REGISTERED PATIENTS WITH EASILY ACCESSIBLE, COMPREHENSIVE, AND UP-TO-DATE WITH INFORMATION ABOUT ALL BRANDS OF IMMUNE GLOBULINS, BLOOD CLOTTING FACTORS, ALPHA-1 PROTEINASE INHIBITORS, AND OTHER LIFESAVING PLASMA PROTEIN THERAPIES. MAINTAINING REGISTRANT CONFIDENTIALITY IS A PRIMARY CONSIDERATION. TO ENSURE CONFIDENTIALITY, THE PATIENT NOTIFICATION SYSTEM IS OPERATED AN INDEPENDENT VENDOR THAT SPECIALIZES IN PHARMACEUTICAL NOTIFICATIONS. ALL REGISTRANTS, PATIENTS, PHYSICIANS, FAMILY MEMBERS, NURSES, OR PHARMACISTS, ARE GUARANTEED THAT THEIR INFORMATION IS NEVER SHARED NOR IS IT ACCESSIBLE BY ANYONE OTHER THAN THE THIRD-PARTY COMPANY THAT HOUSES THE COMPUTERS TO RUN THE SYSTEM AND SEND THE NOTIFICATIONS.
- THE NORTH AMERICA DATA PROGRAM IS A VOLUNTARY MANUFACTURER INITIATIVE UNDERTAKEN IN RESPONSE TO DRUG SHORTAGE CONCERNS, AND IS INTENDED TO PROVIDE A RELIABLE, NATION-WIDE ASSESSMENT OF THE AVAILABILITY OF THESE LIFE-SAVING THERAPIES IN THE UNITED STATES. PPTA'S WEB-BASED SYSTEM PROVIDES AGGREGATE, MONTHLY DISTRIBUTION DATA FOR THE FOLLOWING CATEGORIES OF PLASMA PROTEIN THERAPIES: 1. ALBUMIN 5% 2. ALBUMIN 25% 3. IMMUNE GLOBULIN (IG) 4. PLASMA-DERIVED FACTOR VIII 5. RECOMBINANT FACTOR VIII
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | 990 on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 52-1800187
- Tax-exempt status
- 501(c)(6): Business league or chamber of commerce
- Donations deductible
- No
- Exempt since
- 1993
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Assets (IRS master file)
- $11,603,413
- Income (IRS master file)
- $14,575,171
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2025 | $14,575,171 | $15,873,570 | $11,603,413 | XML |
| 990 | December 2024 | $14,975,704 | $16,177,207 | $12,791,836 | XML |
| 990 | December 2023 | $15,001,344 | $14,444,061 | $12,157,727 | XML |
| 990 | December 2022 | $16,106,524 | $13,065,775 | $10,684,709 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 52-1800187).
Questions about PLASMA PROTEIN THERAPEUTICS ASSOCIATION
- What is the EIN of PLASMA PROTEIN THERAPEUTICS ASSOCIATION?
- The employer identification number (EIN) of PLASMA PROTEIN THERAPEUTICS ASSOCIATION is 52-1800187.
- Is PLASMA PROTEIN THERAPEUTICS ASSOCIATION tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(6) since 1993.
- Are donations to PLASMA PROTEIN THERAPEUTICS ASSOCIATION tax-deductible?
- No. The IRS master file says contributions to it are not deductible.
- Which annual return does PLASMA PROTEIN THERAPEUTICS ASSOCIATION file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of PLASMA PROTEIN THERAPEUTICS ASSOCIATION due?
- The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did PLASMA PROTEIN THERAPEUTICS ASSOCIATION last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2025.
- Who is the principal officer of PLASMA PROTEIN THERAPEUTICS ASSOCIATION?
- The 990 for the year ended December 31, 2025 names EUGENE STROSHANE.
- Who are the officers and directors of PLASMA PROTEIN THERAPEUTICS ASSOCIATION?
- The 990 for the year ended December 31, 2025 lists 13 people; 10 received compensation from the organization, the highest $747,615 (ANITA SPEAR, PRESIDENT &).
- How much revenue does PLASMA PROTEIN THERAPEUTICS ASSOCIATION have?
- On its 990 for the year ended December 31, 2025 it reported revenue of $14,575,171, expenses of $15,873,570 and total assets of $11,603,413 at year end.
Other nonprofits in ANNAPOLIS
- LUMINIS HEALTH ANNE ARUNDEL MEDICAL CENTER INC EIN 52-1169362 · last filed 990 for 2025
- LUMINIS HEALTH DOCTORS COMMUNITY MEDICAL CENTER INC EIN 52-1638026 · last filed 990 for 2025
- PHYSICIAN ENTERPRISE LLC EIN 27-0263214 · last filed 990 for 2025
- UNITED ASSOCIATION OF JOURNEYMEN & APPRENTICES OF THE PLUMBING & PIPE EIN 53-0159020 · last filed 990 for 2025
- LUMINIS HEALTH INC EIN 52-1622253 · last filed 990 for 2025
- ST JOHNS COLLEGE EIN 52-0591421 · last filed 990 for 2025
- UNITED STATES NAVAL ACADEMY FOUNDATION INC EIN 23-7003516 · last filed 990 for 2025
- PUBLIC LIBRARY ASSOCIATION OF ANNAPOLIS AND A A CO INC EIN 52-6001871 · last filed 990 for 2025